Abstract
It has been shown that tumor necrosis factor receptor-2 (TNFR2) stimulation leads to degradation of TNF receptor associated factor-2 (TRAF2) and inhibition of TNFR1-induced activation of NFκB and JNK. Here, we show that TRAF1 inhibits TNFR2-induced proteasomal degradation of TRAF2 and relieves TNFR1-induced activation of NFκB from the inhibitory effect of TNFR2. TRAF1 co-recruited with TRAF2 to both TNF receptors. Despite lacking an amino-terminal RING/zinc-finger domain, TRAF1 did not interfere with TNFR1-induced activation of JNK and NFκB. It is noted that physiological expression levels of TRAF1 enhanced NFκB activation and interleukin-8 (IL8) production induced by TNFR2. Thus, TRAF1 shifts the quality of integrated TNFR1–TNFR2 signaling from apoptosis induction to proinflammatory NFκB signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- RIP:
-
receptor-interacting protein
- IL8:
-
interleukin-8
- MEF:
-
murine embryonal fibroblasts
- NFκB:
-
nuclear factor κB
- TNF:
-
tumor necrosis factor
- TNFR1/2:
-
TNF receptor-1/2
- TRAF1/2:
-
TNF receptor-associated factor-1/2
References
Arron JR, Pewzner-Jung Y, Walsh MC, Kobayashi T, Choi Y . (2002). Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 196: 923–934.
Baxter GT, Kuo RC, Jupp OJ, Vandenabeele P, MacEwan DJ . (1999). Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 274: 9539–9547.
Brown KD, Hostager BS, Bishop GA . (2002). Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem 277: 19433–19438.
Carpentier I, Beyaert R . (1999). TRAF1 is a TNF inducible regulator of NF-kappaB activation. FEBS Lett 460: 246–250.
Chan FK, Lenardo MJ . (2000). A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol 30: 652–660.
Chen ZJ . (2005). Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758–765.
Declercq W, Denecker G, Fiers W, Vandenabeele P . (1998). Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol 161: 390–399.
Dietz AB, Bulur PA, Emery RL, Winters JL, Epps DE, Zubair AC et al. (2006). A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 46: 2083–2089.
Eliopoulos AG, Davies C, Knox PG, Gallagher NJ, Afford SC, Adams DH et al. (2000). CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol Cell Biol 20: 5503–5515.
Fotin-Mleczek M, Henkler F, Hausser A, Glauner H, Samel D, Graness A et al. (2004). Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. J Biol Chem 279: 677–685.
Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I et al. (2002). Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 115: 2757–2770.
Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC et al. (1999). Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18: 3034–3043.
Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, Ronai Z . (2004). Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 23: 322–332.
Henkler F, Baumann B, Fotin-Mleczek M, Weingartner M, Schwenzer R, Peters N et al. (2003). Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. J Biol Chem 278: 29216–29230.
Hoffmann A, Natoli G, Ghosh G . (2006). Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: 6706–6716.
Irmler M, Steiner V, Ruegg C, Wajant H, Tschopp J . (2000). Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett 468: 129–133.
Jones PL, Ping D, Boss JM . (1997). Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB. Mol Cell Biol 17: 6970–6981.
Krippner-Heidenreich A, Grunwald I, Zimmermann G, Kuhnle M, Gerspach J, Sterns T et al. (2008). Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity. J Immunol 180: 8176–8183.
Lee TH, Shank J, Cusson N, Kelliher MA . (2004). The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 279: 33185–33191.
Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C . (2003). Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18: 655–664.
Li X, Yang Y, Ashwell JD . (2002). TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416: 345–347.
Loetscher H, Stueber D, Banner D, Mackay F, Lesslauer W . (1993). Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 268: 26350–26357.
Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E et al. (2008). Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA 105: 11778–11783.
Muppidi JR, Tschopp J, Siegel RM . (2004). Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21: 461–465.
Murray J, Barbara JA, Dunkley SA, Lopez AF, Van Ostade X, Condliffe AM et al. (1997). Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772–2783.
Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K et al. (2004). Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529–542.
Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, Scheurich P et al. (1999). TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 29: 1785–1792.
Schwenzer R, Siemienski K, Liptay S, Schubert G, Peters N, Scheurich P et al. (1999). The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase. J Biol Chem 274: 19368–19374.
Speiser DE, Lee SY, Wong B, Arron J, Santana A, Kong YY et al. (1997). A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 185: 1777–1783.
Speiser DE, Sebzda E, Ohteki T, Bachmann MF, Pfeffer K, Mak TW et al. (1996). Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol 26: 3055–3060.
Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW et al. (2001). TRAF1 is a negative regulator of TNF signaling enhanced TNF signaling in TRAF1-deficient mice. Immunity 15: 647–657.
Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W . (1995). Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154: 2904–2913.
Vercammen D, Vandenabeele P, Declercq W, Van de CM, Grooten J, Fiers W . (1995). Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine 7: 463–470.
Wajant H . (2003). Death receptors. Essays Biochem 39: 53–71.
Wajant H, Henkler F, Scheurich P . (2001). The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13: 389–400.
Wajant H, Pfizenmaier K, Scheurich P . (2003). Tumor necrosis factor signaling. Cell Death Differ 10: 45–65.
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS . (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680–1683.
Weingartner M, Siegmund D, Schlecht U, Fotin-Mleczek M, Scheurich P, Wajant H . (2002). Endogenous membrane tumor necrosis factor (TNF) is a potent amplifier of TNF receptor 1-mediated apoptosis. J Biol Chem 277: 34853–34859.
Weiss T, Grell M, Hessabi B, Bourteele S, Müller G, Scheurich P et al. (1997). Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J Immunol 158: 2398–2404.
Wong GH, Goeddel DV . (1988). Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242: 941–944.
Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, Ashwell JD . (2005). TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 24: 1886–1898.
Zhao Y, Conze DB, Hanover JA, Ashwell JD . (2007). Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J Biol Chem 282: 7777–7782.
Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ . (1995). Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348–351.
Acknowledgements
The project was supported by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 487, project B7, HE 5275/2-1 and Wa1025/8-1), IZKF Würzburg (project A-49) and Weyth Biopharma (Forschungspreis Rheumatologie 2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wicovsky, A., Henkler, F., Salzmann, S. et al. Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1–TNFR2 cooperation. Oncogene 28, 1769–1781 (2009). https://doi.org/10.1038/onc.2009.29
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.29
Keywords
This article is cited by
-
ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
Cellular Oncology (2023)
-
COVID-19 and the role of cytokines in this disease
Inflammopharmacology (2022)
-
Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling
Cell Death & Disease (2019)
-
TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP
Cell Death & Disease (2019)
-
The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease
Nature Immunology (2017)